|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00950 LEE'S PHARM
Nominal 
1.200 0.000 (0.000%) Profitability Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| ROAA (%) | 3.023% | 3.380% | 0.589% | 1.598% | 57.684% |
| ROAE (%) | 4.973% | 5.045% | 0.843% | 2.337% | 86.130% |
| Return on Capital Employed (%) | 3.940% | 5.042% | 0.745% | 2.406% | 73.211% |
Margin Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Gross Profit Margin (%) | 50.806% | 53.812% | 52.355% | 62.503% | 63.680% |
| EBITDA Margin (%) | 16.701% | 18.482% | 18.187% | 18.381% | 167.399% |
| Pre-tax Profit Margin (%) | 5.076% | 7.008% | 2.923% | 5.503% | 155.539% |
| Net Profit Margin (%) | 6.402% | 6.650% | 1.586% | 4.159% | 156.945% |
Liquidity Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Current Ratio (X) | 1.035 X | 1.017 X | 1.012 X | 1.002 X | 1.044 X |
| Quick Ratio (X) | 0.712 X | 0.644 X | 0.553 X | 0.619 X | 0.685 X |
Leverage Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Total Liabilities / Total Assets(%) | 45.141% | 40.833% | 32.175% | 33.770% | 34.253% |
| Total Debt / Total Assets (%) | 8.957% | 8.683% | 7.062% | 5.877% | 7.345% |
| Net Debt / Total Assets (%) | -1.144% | 0.399% | 1.146% | -0.928% | -0.286% |
| Total Debt / Shareholders' Funds (%) | 15.166% | 13.761% | 10.012% | 8.497% | 10.839% |
| Long Term Debt / Shareholders' Funds (%) | 4.258% | 4.210% | 3.657% | 4.154% | 3.731% |
| Net Debt / Shareholders' Funds (%) | -1.937% | 0.633% | 1.625% | -1.341% | -0.422% |
| Net Cash / (Debt) ($) | 39.628M | (10.453M) | (33.140M) | 25.807M | 10.391M |
| Net Cash / (Debt) per share ($) | 0.067 | (0.018) | (0.056) | 0.044 | 0.018 |
| Total Debt / Capital Employed (%) | 13.295% | 12.309% | 9.106% | 7.669% | 9.842% |
| Interest Coverage Ratio (X) | -- | 8.098 X | 3.730 X | 11.252 X | 448.177 X |
Efficiency Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Inventory Turnover (Day) | 168.425 Day | 165.285 Day | 199.089 Day | 229.161 Day | 295.958 Day |
| Receivables Turnover (Day) | 44.711 Day | 32.028 Day | 33.946 Day | 41.380 Day | 47.262 Day |
| Payables Turnover (Day) | 40.237 Day | 28.173 Day | 30.407 Day | 24.256 Day | 19.650 Day |
| Remarks: | Real time quote last updated: 01/04/2026 15:58 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 91,938 |
| %Change | -1.247% |
| EPS / (LPS) | HKD 0.156 |
| NBV Per Share ($) | HKD 3.474 |